AC
COGT icon

Aaron Cowen’s Cogent Biosciences COGT Stock Holding History

Aaron Cowen’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-316,000
Closed -$2.12M – 101
2024
Q1 		$2.12M Sell
316,000
-3,394,539
-91% -$21M 0.08% 74
2023
Q4 		$21.8M Buy
3,710,539
+657,239
+22% +$5.04M 0.99% 33
2023
Q3 		$29.8M Buy
3,053,300
+833,607
+38% +$9.89M 1.61% 20
2023
Q2 		$26.3M Buy
2,219,693
+400,000
+22% +$4.59M 1.41% 25
2023
Q1 		$19.6M Buy
1,819,693
+8,297
+0.5% +$106K 0.83% 41
2022
Q4 		$20.9M Sell
1,811,396
-51,204
-3% -$635K 0.88% 39
2022
Q3 		$27.8M Buy
1,862,600
+1,262,600
+210% +$17.3M 1.15% 35
2022
Q2 		$5.41M Buy
+600,000
New +$4.1M 0.21% 63

Other funds holding COGT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Aaron Cowen's COGT Position: Q2 2024 in Review

Aaron Cowen sold out of Cogent Biosciences (COGT) in Q2 2024, closing a stake of 316,000 shares — an estimated $2.12M sold.

Aaron Cowen first reported a position in COGT in Q2 2022 and held it in 8 quarters. The position peaked at $29.8M in Q3 2023. 149 funds tracked by Wall St. Rank hold COGT as of Q2 2024.

  • Aaron Cowen reported no remaining Cogent Biosciences position as of Q2 2024 after selling out during the quarter.
  • Aaron Cowen sold 316,000 Cogent Biosciences shares in Q2 2024, an estimated $2.12M.
  • Aaron Cowen first reported a position in Cogent Biosciences in Q2 2022 and held it in 8 quarters.
  • Aaron Cowen's Cogent Biosciences position peaked at $29.8M in Q3 2023.
  • 149 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2024.

Based on Suvretta Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.